09th week of 2021 patent applcation highlights part 10

Patent application number	Title	Published
09th week of 2021 patent applcation highlights part 10
20210059996	SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION	2021-03-04
20210059997	PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR CATARACT, MEDICINAL COMPOSITION FOR PREVENTING AND/OR TREATING CATARACT, USE OF PPAR ACTIVATOR FOR PRODUCING SAME, AND EYEDROPS	2021-03-04
20210059998	OPHTHALMIC COMPOSITION	2021-03-04
20210059999	COMBINATION TREATMENT OF SARCOGLYCANOPATHIES	2021-03-04
20210060000	NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF	2021-03-04
20210060001	THERAPEUTIC TARGETING OF THE BAP1 COMPLEX IN CANCER	2021-03-04
20210060002	METHODS OF PREVENTING OR TREATING FLAVIVIRUS VIRUS INFECTIONS AND METHODS OF INHIBITING THE ENTRY OF FLVIVIRUS, ENTEROVIRUS OR LENTIVIRUS INTO HOST CELLS	2021-03-04
20210060003	TREATMENT OF CANCER	2021-03-04
20210060004	BUPROPION AS A MODULATOR OF DRUG ACTIVITY	2021-03-04
20210060005	BUPROPION AS A MODULATOR OF DRUG ACTIVITY	2021-03-04
20210060006	COMPOSITIONS AND METHODS FOR TREATING GLIOBLASTOMA BY MODULATING A MGMT ENHANCER	2021-03-04
20210060007	ANTI-INFLAMMATORY COMPOSITION	2021-03-04
20210060008	METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS	2021-03-04
20210060009	NOVEL METHODS	2021-03-04
20210060010	ORGANIC COMPOUNDS	2021-03-04
20210060011	CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZ- O[1,2-a]PYRAZIN-8-AMINE	2021-03-04
20210060012	METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS	2021-03-04
20210060013	Method for Preventing Triple Negative Breast Cancer in Predisposed Subjects	2021-03-04
20210060014	COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS	2021-03-04
20210060015	THERAPEUTIC DRUG FOR DYSKINESIA	2021-03-04
20210060016	ANTICANCER AGENT	2021-03-04
20210060017	METHOTREXATE OPHTHALMIC SOLUTION	2021-03-04
20210060018	TOPICAL ADMINISTRATION OF MEK INHIBITING AGENTS FOR THE TREATMENT OF SKIN DISORDERS	2021-03-04
20210060019	PHARMACEUTICAL COMPOSITIONS COMPRISING IBRUTINIB	2021-03-04
20210060020	PHARMACEUTICAL FORMULATIONS	2021-03-04
20210060021	Method of Adjuvant Cancer Treatment	2021-03-04
20210060022	TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS	2021-03-04
20210060023	Cycloalkyl-Diamines for the Treatment of Inflammation	2021-03-04
20210060024	GENERATION OF MUSCLE LINEAGE CELLS AND THERAPEUTIC USES THEREOF	2021-03-04
20210060025	COMBINATION THERAPY FOR TREATING CANCER	2021-03-04
20210060026	COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4	2021-03-04
20210060027	SUBSTITUTED BENZENE COMPOUNDS	2021-03-04
20210060028	DNA-PK INHIBITORS	2021-03-04
20210060029	Use of Minaprine to Reduce Tumor Growth	2021-03-04
20210060030	METHOD FOR TREATING CANCER	2021-03-04
20210060031	USE OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS FOR TREATMENT OF VASCULAR MALFORMATIONS	2021-03-04
20210060033	ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS	2021-03-04
20210060034	The Pharmaceutical Composition Intended to Inhibit HIV Infectivity in Order to Treat the Acquired Immune Deficiency Syndrome (AIDS) and Its Complications	2021-03-04
20210060035	APPLICATION OF COMPOUND IN PREPARATION OF DRUG FOR TREATMENT OF HAEMORRHAGIC STROKE	2021-03-04
20210060036	LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS	2021-03-04
20210060037	Methods For Producing Chemoembolic Agents For The Delivery Of Anti-Cancer Agents	2021-03-04
20210060038	COMPOSITIONS FOR ELIMINATING BACTERIAL PROMOTORS OF COLORECTAL CANCER BY INTRALUMINAL APPLICATION	2021-03-04
20210060039	COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF	2021-03-04
20210060040	CANNABINOID RECEPTOR MODULATORS	2021-03-04
20210060041	STING AGONISTS FOR TREATING BLADDER CANCER AND SOLID TUMORS	2021-03-04
20210060042	Patentiflorin A Analogs as Antiviral Agents	2021-03-04
20210060043	METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION	2021-03-04
20210060044	METHODS FOR TREATING BLADDER CANCER BY ACTIVATION OF HEDGEHOG SIGNALING USING A METHYLATION INHIBITOR	2021-03-04
20210060045	PHARMACEUTICAL PASTE FORMULATIONS FOR SITE SPECIFIC APPLICATION	2021-03-04
20210060046	USE OF VERBASCOSIDE IN PREPARATION OF DRUG FOR PREVENTING OR TREATING GLOMERULAR PODOCYTE INJURED RENAL DISEASE	2021-03-04
20210060047	COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND RUTIN IN CO-MICRONIZED FORM	2021-03-04
20210060048	COMPOSITIONS FOR IMPROVING JOINT HEALTH	2021-03-04
20210060049	PHYTOCHEMICAL-ANTIBIOTIC COMBINATION FOR THE TREATMENT OF A BACTERIAL INFECTION	2021-03-04
20210060050	N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto	2021-03-04
20210060051	COMBINED MODALITIES FOR NUCLEOSIDES AND/OR NADPH OXIDASE (NOX) INHIBITORS AS MYELOID-SPECIFIC ANTIVIRAL AGENTS	2021-03-04
20210060052	IN SITU METHODS OF INDUCING OF IMMUNE RESPONSE	2021-03-04
20210060053	DEVELOPMENT OF POLYLYSINE:EPIGALLOCATECHIN-3-O-GALLATE AND DSRNA POLYPLEXES FOR CONTROL OF MOSQUITOES	2021-03-04
20210060054	NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES AND METHODS OF MAKING SAME	2021-03-04
20210060055	METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE	2021-03-04
20210060056	OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION	2021-03-04
20210060057	NEW USE OF DEXTRAN SULFATE	2021-03-04
20210060058	COMPOSITIONS AND METHODS FOR TREATING HYDROGEN SULFIDE-MEDIATED HYPERDYNAMIC CIRCULATION	2021-03-04
20210060059	TREATMENT OF MYOPIC PROGRESSION	2021-03-04
20210060060	COMPOSITIONS AND METHODS FOR THE TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD	2021-03-04
20210060061	SELENIUM-DOPED BLACK PHOSPHORUS PRODRUG AND PREPARATION METHOD THEREFOR	2021-03-04
20210060062	METHODS OF PRODUCING HUMAN RPE CELLS AND PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS	2021-03-04
20210060063	Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products	2021-03-04
20210060064	METHODS OF TREATING AGING-RELATED DISORDERS	2021-03-04
20210060065	Therapeutic Protein Compositions and Methods of Making and Using the Same	2021-03-04
20210060066	COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS	2021-03-04
20210060067	ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME	2021-03-04
20210060068	BIOLOGICALLY RELEVANT ORTHOGONAL CYTOKINE/RECEPTOR PAIRS	2021-03-04
20210060069	COUPLED REDIRECTED CELLS AND USES THEREOF	2021-03-04
20210060070	ADOPTIVE CELL THERAPY AND METHODS OF DOSING THEREOF	2021-03-04
20210060071	Chimeric Antigen Receptor T Regulatory Cells for the Treatment of Atherosclerosis	2021-03-04
20210060072	METHODS AND COMPOSITIONS FOR TREATING CANCER	2021-03-04
20210060073	CANCER IMMUNOTHERAPY USING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS	2021-03-04
20210060074	PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS	2021-03-04
20210060075	METHODS FOR IDENTIFYING ANTIGEN-SPECIFIC T CELL RECEPTORS	2021-03-04
20210060076	T CELL RECEPTORS TARGETING PIK3CA MUTATIONS AND USES THEREOF	2021-03-04
20210060077	PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS	2021-03-04
20210060078	PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS	2021-03-04
20210060079	CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF	2021-03-04
20210060080	CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF	2021-03-04
20210060081	COMPOSITION FOR IMPROVING, PREVENTING OR TREATING SKIN DISEASE COMPRISING INDUCED PLURIPOTENCY STEM CELL-DERIVED MESENCHYMAL STEM CELLS PRETREATED WITH INTERFERON GAMMA AND EXOSOMES DERIVED THEREFROM	2021-03-04
20210060082	Ameliorating Nervous Systems Disorders	2021-03-04
20210060083	METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF	2021-03-04
20210060084	AMNIOTIC FLUID FORMULATION FOR MODULATING IMMUNE RESPONSES	2021-03-04
20210060085	COMPOSITIONS AND METHODS FOR TREATING DIABETIC FOOT AND OTHER INJURIES AND SORES	2021-03-04
20210060086	COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER	2021-03-04
20210060087	TREATMENT AND PREVENTION OF PATHOGENIC BACTERIAL OVERGROWTH USING BUTYRATE-PRODUCING BACTERIA	2021-03-04
20210060088	COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT	2021-03-04
20210060089	METHODS FOR DETECTING RISK OF HAVING A BLOODSTREAM INFECTION AND COMPOSITIONS FOR REDUCING THE RISK	2021-03-04
20210060090	COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED THERETO	2021-03-04
20210060091	Bacteroides ovatus for Relieving Endotoxin Infection and Application thereof	2021-03-04
20210060092	PROBIOTIC AND PROBIOTIC COMBINATION FOR INHIBITION OF VANCOMYCIN-RESISTANT ENTEROCOCCI AND USE THEREOF	2021-03-04
20210060093	COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER	2021-03-04
20210060094	COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER	2021-03-04
20210060095	COMBINATION THERAPY FOR TREATING OR PREVENTING CANCER	2021-03-04
20210060096	METHODS AND COMPOSITIONS USING BIFIDOBACTERIUM LONGUM TO MODULATE EMOTIONAL REACTIVITY AND TREAT OR PREVENT SUB-CLINICAL MOOD DISTURBANCES	2021-03-04

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees